Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application

被引:155
作者
Fox, BP [1 ]
Kandpal, RP [1 ]
机构
[1] Fordham Univ, Dept Biol Sci, Bronx, NY 10458 USA
关键词
Eph receptor; ephrin; matrigel invasion; mammary gland development; breast cancer; breast carcinoma cell lines; diagnostic and prognostic markers of breast carcinoma; MCF-10A; MCF-7; MDA-MB-231; expression profile;
D O I
10.1016/j.bbrc.2004.04.102
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The Eph family of receptors, with 14 members in humans, makes up the largest group of receptor tyrosine kinases. These Eph receptors, along with their ligands, the 8 members of the ephrin family of ligands are involved in diverse developmental functions, including hindbrain development in vertebrates, tissue patterning, and angiogenesis. These Eph receptors and ephrin ligands have also been identified as important regulators in the development and progression of cancer. We have presented here a systematic and comprehensive investigation of the Eph/ephrin expression profiles of MCF-10A, MCF-7, and MDA-MB-231 cells representing normal breast, non-invasive breast tumor, and invasive tumor, respectively, based on their characteristic phenotypes in Matrigel matrix. The data have allowed us to correlate the gene expression profile with the cell phenotype that has potential application in tumor diagnostics. We demonstrate here that upregulation of EphA2, A7, A10, and ephrinA2 and B3 is likely involved in tumorigenesis and/or invasiveness, while downregulation of EphA1, A3, A4, A8, B3, B4, B6, and ephrinA1 and B1 may be particularly important in invasiveness. Based on these results we discuss the role of EphA2 and ephrinA1 combination in malignancy. The data have provided clues as to the importance of these molecules in the progression of breast cancer and specifically identified EphB6, a kinase-deficient receptor, which is downregulated in the most aggressive cell line, as reported for several other cancer types including neuroblastoma and melanoma suggesting its potential as a prognostic indicator in breast cancer as well. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:882 / 892
页数:11
相关论文
共 51 条
  • [21] Kinch MS, 2003, CLIN CANCER RES, V9, P613
  • [22] Mechanisms and functions of EPH and ephrin signalling
    Kullander, K
    Klein, R
    [J]. NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (07) : 475 - 486
  • [23] Lal A, 1999, CANCER RES, V59, P5403
  • [24] Coexpression of ephrin-Bs and their receptors in colon carcinoma
    Liu, WB
    Ahmad, SA
    Jung, YD
    Reinmuth, N
    Fan, F
    Bucana, CD
    Ellis, LM
    [J]. CANCER, 2002, 94 (04) : 934 - 939
  • [25] Lu M, 2003, CANCER RES, V63, P3425
  • [26] The protein kinase complement of the human genome
    Manning, G
    Whyte, DB
    Martinez, R
    Hunter, T
    Sudarsanam, S
    [J]. SCIENCE, 2002, 298 (5600) : 1912 - +
  • [27] Expression of a kinase-defective Eph-like receptor in the normal human brain
    Matsuoka, H
    Iwata, N
    Ito, M
    Shimoyama, M
    Nagata, A
    Chihara, K
    Takai, S
    Matsui, T
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 235 (03) : 487 - 492
  • [28] EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma
    Miyazaki, T
    Kato, H
    Fukuchi, M
    Nakajima, M
    Kuwano, H
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2003, 103 (05) : 657 - 663
  • [29] Morin Patrice J, 2003, Cancer Treat Res, V115, P169
  • [30] Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC
    Morin, PJ
    Sparks, AB
    Korinek, V
    Barker, N
    Clevers, H
    Vogelstein, B
    Kinzler, KW
    [J]. SCIENCE, 1997, 275 (5307) : 1787 - 1790